| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.257 | 16.527 | 16.130 | 35.928 | 45.521 | 24.958 | 10.891 | 14.226 | 31.319 |
| Total Income - EUR | - | 3.257 | 16.886 | 16.130 | 36.052 | 45.455 | 24.958 | 10.891 | 14.226 | 31.555 |
| Total Expenses - EUR | - | 2.017 | 11.371 | 12.399 | 19.236 | 23.963 | 14.773 | 7.730 | 9.633 | 24.466 |
| Gross Profit/Loss - EUR | - | 1.239 | 5.515 | 3.731 | 16.816 | 21.492 | 10.185 | 3.162 | 4.594 | 7.089 |
| Net Profit/Loss - EUR | - | 1.142 | 5.019 | 3.247 | 15.738 | 20.304 | 9.436 | 2.835 | 3.859 | 5.955 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Madidramax 03 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 3.174 | 2.727 | 3.211 | 2.284 | 1.466 | 1.103 | 733 | 364 |
| Current Assets | - | 2.063 | 5.779 | 10.585 | 24.066 | 44.148 | 54.312 | 57.581 | 20.999 | 26.867 |
| Inventories | - | 1.993 | 5.297 | 10.054 | 14.192 | 22.790 | 22.571 | 21.321 | 18.540 | 8.608 |
| Receivables | - | 0 | 299 | 293 | 288 | 282 | 318 | 319 | 318 | 9.979 |
| Cash | - | 70 | 183 | 237 | 9.586 | 21.076 | 31.424 | 35.941 | 2.141 | 8.279 |
| Shareholders Funds | - | 1.186 | 6.185 | 9.319 | 24.877 | 44.709 | 53.154 | 56.154 | 19.409 | 25.256 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 877 | 2.768 | 3.992 | 2.400 | 1.723 | 2.624 | 2.530 | 2.323 | 1.976 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Madidramax 03 S.r.l.